Company Profile

Oxygense LLC
Profile last edited on: 9/30/2013      CAGE: 5CSJ6      UEI: L67MNCFGML74

Business Identifier: Predictive monitoring system for better acute trauma care
Year Founded
2009
First Award
2010
Latest Award
2010
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3160 Chestnut Street Suite 200
Philadelphia, PA 19104
   (609) 933-2885
   mpoisel@ctt.upenn.edu
   www.oxygense.com
Location: Single
Congr. District: 03
County: Philadelphia

Public Profile

Oxygense's has developed a simple monitoring system able to give real-time measurements of oxygen pressure and carbon dioxide pressure in peripheral tissue. These measurements can be used to predict early onset of hemorrhagic shock, quantify efficacy of cardiac resuscitation, and improve standard of care for the critically ill. Trauma is the leading cause of death of people between the ages of 1 and 44. Hemorrhagic shock is the leading cause of death from trauma. Approximately 60% of civilian trauma deaths, and up to 90% of military trauma deaths, are from hemorrhagic shock. The Oxygense technology meets a real clinical need. Currently, there is no effective technology available on the market able to detect early onset of hemorrhagic shock.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 1 NIH $199,744
Project Title: A Real-Time, Minimally Invasive Monitoring System For Early Detection Of Shock

Key People / Management

  Anne-Marie Maman -- President and Founder

Company News

There are no news available.